Dextran

Dextran (Dextran 40) has an inhibitory effect on thrombocyte aggregation and coagulation factors and is used as a plasma volume expander.

Product Specifications

CAS Number

[9004-54-0]

Product Name Alternative

Dextran 40

UNSPSC

12352005

Hazard Statement

H303

Target

Bacterial

Type

Oligonucleotides

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease; Cancer

Assay Protocol

https://www.medchemexpress.com/dextran.html

Purity

95.0

Solubility

H2O : 100 mg/mL (ultrasonic)

Smiles

[Dextran]

Molecular Weight

40000.00

Precautions

H303

References & Citations

[1]Bark BP, et al. Infusion rate and plasma volume expansion of dextran and albumin in the septic guinea pig. Acta Anaesthesiol Scand. 2014 Jan;58 (1) :44-51.|[2]Santos ES, et al. Anti-inflammatory activity of herb products from Licania rigida Benth. Complement Ther Med. 2019 Aug;45:254-261.|[3]REDEI A. Investigations on the mechanism of dextran induced oedema in rats. Med Exp Int J Exp Med. 1962;6:73-8. |[4]GOEZSY B, et al. INVESTIGATIONS INTO THE MECHANISM OF DEXTRANINDUCED EDEMA IN RATS. Can J Biochem Physiol. 1963 Sep;41:1855-63.